< Back to catalogue
Iron sucrose
August 4, 2026PHARMAZAC
Mavacamten
Mavacamten | Cardiac Myosin Inhibitor | Business Development
| HARD CAPSULES 2.5MG/CAP |
| HARD CAPSULES 5MG/CAP |
| HARD CAPSULES 10MG/CAP |
| HARD CAPSULES 15MG/CAP |
| HARD CAPSULES 2.5MG/CAP |
| HARD CAPSULES 5MG/CAP |
| HARD CAPSULES 10MG/CAP |
| HARD CAPSULES 15MG/CAP |
| ACTIVE SUBSTANCE | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| STATUS | In Process |
| THERAPEUTIC AREA |
